View in EDS

Rational Drug Design of Targeted and Enzyme-Cleavable Vitamin E Analogs as a Neoadjuvant to Chemotherapy: In Vitro and In Vivo Evaluation on Reduction of the Cardiotoxicity Side Effect of Doxorubicin.

Saved in:
Bibliographic Details
Title: Rational Drug Design of Targeted and Enzyme-Cleavable Vitamin E Analogs as a Neoadjuvant to Chemotherapy: In Vitro and In Vivo Evaluation on Reduction of the Cardiotoxicity Side Effect of Doxorubicin.
Authors: Pandurangi RS; Sci-Engi-Medco Solutions Inc. (SEMCO), 573, Lexington Landing Pl, St. Charles, Missouri 63303, United States., Cseh O; HRIC 2A25, 3330 Hospital Drive NW, Calgary, AB T2N 4N, Canada., Luchman HA; HRIC 2A25, 3330 Hospital Drive NW, Calgary, AB T2N 4N, Canada., Ma CX; Siteman Cancer Center, Washington University School of Medicine, St. Louis, Missouri 63110, United States., Senadheera SN; Department of Pharmaceutical Chemistry, School of Pharmacy, University of Kansas, Lawrence, Kansas 66047, United States., Forrest ML; Department of Pharmaceutical Chemistry, School of Pharmacy, University of Kansas, Lawrence, Kansas 66047, United States.
Source: ACS pharmacology & translational science [ACS Pharmacol Transl Sci] 2023 Feb 06; Vol. 6 (3), pp. 372-386. Date of Electronic Publication: 2023 Feb 06 (Print Publication: 2023).
Publication Type: Journal Article
Journal Info: Publisher: American Chemical Society Country of Publication: United States NLM ID: 101721411 Publication Model: eCollection Cited Medium: Internet ISSN: 2575-9108 (Electronic) Linking ISSN: 25759108 NLM ISO Abbreviation: ACS Pharmacol Transl Sci Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 36926453
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Rational Drug Design of Targeted and Enzyme-Cleavable Vitamin E Analogs as a Neoadjuvant to Chemotherapy: In Vitro and In Vivo Evaluation on Reduction of the Cardiotoxicity Side Effect of Doxorubicin.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Pandurangi+RS%22">Pandurangi RS</searchLink>; Sci-Engi-Medco Solutions Inc. (SEMCO), 573, Lexington Landing Pl, St. Charles, Missouri 63303, United States.<br /><searchLink fieldCode="AU" term="%22Cseh+O%22">Cseh O</searchLink>; HRIC 2A25, 3330 Hospital Drive NW, Calgary, AB T2N 4N, Canada.<br /><searchLink fieldCode="AU" term="%22Luchman+HA%22">Luchman HA</searchLink>; HRIC 2A25, 3330 Hospital Drive NW, Calgary, AB T2N 4N, Canada.<br /><searchLink fieldCode="AU" term="%22Ma+CX%22">Ma CX</searchLink>; Siteman Cancer Center, Washington University School of Medicine, St. Louis, Missouri 63110, United States.<br /><searchLink fieldCode="AU" term="%22Senadheera+SN%22">Senadheera SN</searchLink>; Department of Pharmaceutical Chemistry, School of Pharmacy, University of Kansas, Lawrence, Kansas 66047, United States.<br /><searchLink fieldCode="AU" term="%22Forrest+ML%22">Forrest ML</searchLink>; Department of Pharmaceutical Chemistry, School of Pharmacy, University of Kansas, Lawrence, Kansas 66047, United States.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101721411%22">ACS pharmacology & translational science</searchLink> [ACS Pharmacol Transl Sci] 2023 Feb 06; Vol. 6 (3), pp. 372-386. <i>Date of Electronic Publication: </i>2023 Feb 06 (<i>Print Publication: </i>2023).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Chemical+Society%22">American Chemical Society </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101721411 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2575-9108 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2225759108%22">25759108 </searchLink><i>NLM ISO Abbreviation: </i>ACS Pharmacol Transl Sci <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36926453
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1021/acsptsci.2c00091
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 372
    Titles:
      – TitleFull: Rational Drug Design of Targeted and Enzyme-Cleavable Vitamin E Analogs as a Neoadjuvant to Chemotherapy: In Vitro and In Vivo Evaluation on Reduction of the Cardiotoxicity Side Effect of Doxorubicin.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Pandurangi RS
      – PersonEntity:
          Name:
            NameFull: Cseh O
      – PersonEntity:
          Name:
            NameFull: Luchman HA
      – PersonEntity:
          Name:
            NameFull: Ma CX
      – PersonEntity:
          Name:
            NameFull: Senadheera SN
      – PersonEntity:
          Name:
            NameFull: Forrest ML
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 06
              M: 02
              Text: 2023 Feb 06
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 2575-9108
          Numbering:
            – Type: volume
              Value: 6
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: ACS pharmacology & translational science
              Type: main
ResultId 1